The DOI matches its Crossref record; 46 of the 46 references it cites were found in a registry or an index.
Appropriate Polypharmacy and Medicine Safety: When Many is not Too Many
Open accessAbstract
The use of multiple medicines (polypharmacy) is increasingly common in middle-aged and older populations. Ensuring the correct balance between the prescribing of 'many' drugs and 'too many' drugs is a significant challenge. Clinicians are tasked with ensuring that patients receive the most appropriate combinations of medications based on the best available evidence, and that medication use is optimised according to patients' clinical needs (appropriate polypharmacy). Historically, polypharmacy has been viewed negatively because of the associated medication safety risks, such as drug interactions and adverse drug events. More recently, polypharmacy has been identified as a risk factor for under-prescribing, such that patients do not receive necessary medications and this can also pose risks to patients' safety and well-being. The negative connotations that have long been associated with the term polypharmacy could potentially be acting as a driving factor for under-prescribing, whereby clinicians are reluctant to prescribe necessary medicines for patients who are already receiving 'many' medicines. It is now recognised that the prescribing of 'many' medicines can be entirely appropriate in patients with several chronic conditions and that the risks of adverse drug events that have been associated with polypharmacy may be greatly reduced when patients' clinical context is taken into consideration. In this article, we outline the current perspectives on polypharmacy and make the case for adopting the term 'appropriate polypharmacy' in differentiating between the prescribing of 'many' drugs and 'too many' drugs. We also outline the inherent challenges in doing so and provide recommendations for future clinical practice and research.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Barnett, K., Mercer, S. W., Norbury, M., Watt, G., Wyke, S., & Guthrie, B. (2012) · The Lancet · doi:10.1016/s0140-6736(12)60240-2 · Cited by 6,972
STOPP/START criteria for potentially inappropriate prescribing in older people: version 2
O'Mahony, D., O'Sullivan, D., Byrne, S., O'Connor, M. N., Ryan, C., & Gallagher, P. (2014) · Age and Ageing · doi:10.1093/ageing/afu145 · Cited by 2,397
Self-citationClinical consequences of polypharmacy in elderly
Maher, R. L., Hanlon, J., & Hajjar, E. R. (2014) · Expert Opinion on Drug Safety · doi:10.1517/14740338.2013.827660 · Cited by 1,938
Developing core outcome sets for clinical trials: issues to consider
Williamson, P. R., Altman, D. G., Blazeby, J. M., Clarke, M., Devane, D., Gargon, E., & Tugwell, P. (2012) · Trials · doi:10.1186/1745-6215-13-132 · Cited by 1,661
Reducing Inappropriate Polypharmacy: The Process of Deprescribing
Scott, I. A., Hilmer, S. N., Reeve, E., Potter, K., Le Couteur, D., Rigby, D., Gnjidic, D., Del Mar, C. B., Roughead, E. E., Page, A., et al. (2015) · JAMA Internal Medicine · doi:10.1001/jamainternmed.2015.0324 · Cited by 1,584
Gallagher, P., Ryan, C., Byrne, S., Kennedy, J., & OMahony, D. (2008) · Int. Journal of Clinical Pharmacology and Therapeutics · doi:10.5414/cpp46072 · Cited by 1,506
Self-citationAppropriate prescribing in elderly people: how well can it be measured and optimised?
Spinewine, A., Schmader, K. E., Barber, N., Hughes, C., Lapane, K. L., Swine, C., & Hanlon, J. T. (2007) · The Lancet · doi:10.1016/s0140-6736(07)61091-5 · Cited by 1,090
Self-citationThe rising tide of polypharmacy and drug-drug interactions: population database analysis 1995–2010
Guthrie, B., Makubate, B., Hernandez-Santiago, V., & Dreischulte, T. (2015) · BMC Medicine · doi:10.1186/s12916-015-0322-7 · Cited by 838
Drug-Drug Interactions Among Elderly Patients Hospitalized for Drug Toxicity
Juurlink, D. N., Mamdani, M., Kopp, A., Laupacis, A., & Redelmeier, D. A. (2003) · JAMA · doi:10.1001/jama.289.13.1652 · Cited by 761
Interventions to improve the appropriate use of polypharmacy for older people
Patterson, S. M., Cadogan, C. A., Kerse, N., Cardwell, C. R., Bradley, M. C., Ryan, C., & Hughes, C. (2014) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd008165.pub3 · Cited by 754
Self-citationBormate, A. B., Leboit, P. E., & McCalmont, T. H. (2008) · Archives of Dermatology · doi:10.1001/archderm.144.8.1020 · Cited by 731
Health Outcomes Associated with Polypharmacy in Community‐Dwelling Older Adults: A Systematic Review
Fried, T. R., O'Leary, J., Towle, V., Goldstein, M. K., Trentalange, M., & Martin, D. K. (2014) · Journal of the American Geriatrics Society · doi:10.1111/jgs.13153 · Cited by 721
Development and Validation of the Medication Regimen Complexity Index
George, J., Phun, Y.-T., Bailey, M. J., Kong, D. C., & Stewart, K. (2004) · Annals of Pharmacotherapy · doi:10.1345/aph.1d479 · Cited by 557
Viktil, K. K., Blix, H. S., Moger, T. A., & Reikvam, A. (2007) · British Journal of Clinical Pharmacology · doi:10.1111/j.1365-2125.2006.02744.x · Cited by 537
Hughes, L. D., McMurdo, M. E. T., & Guthrie, B. (2013) · Age and Ageing · doi:10.1093/ageing/afs100 · Cited by 506
Polypharmacy: Misleading, but manageable
Bushardt, R. (2008) · Clinical Interventions in Aging · doi:10.2147/cia.s2468 · Cited by 489
Cahir, C., Fahey, T., Teeling, M., Teljeur, C., Feely, J., & Bennett, K. (2010) · British Journal of Clinical Pharmacology · doi:10.1111/j.1365-2125.2010.03628.x · Cited by 418
Reeve, E., Shakib, S., Hendrix, I., Roberts, M. S., & Wiese, M. D. (2014) · British Journal of Clinical Pharmacology · doi:10.1111/bcp.12386 · Cited by 388
Reduction of Polypharmacy in the Elderly: A Systematic Review of the Role of the Pharmacist
Rollason, V., & Vogt, N. (2003) · Drugs & Aging · doi:10.2165/00002512-200320110-00003 · Cited by 361
Leendertse, A., Egberts, T. C. G., Stoker, L., & van den Bemt, P. M. L. A. (2008) · EUR Research Repository (Erasmus University Rotterdam) · Cited by 360
Prinsen, C. A. C., Vohra, S., Rose, M. R., King-Jones, S., Ishaque, S., Bhaloo, Z., Adams, D., & Terwee, C. B. (2014) · Trials · doi:10.1186/1745-6215-15-247 · Cited by 332
American Geriatrics Society Expert Panel on the Care of Older Adults with Multimorbidity (2012) · Journal of the American Geriatrics Society · doi:10.1111/j.1532-5415.2012.04187.x · Cited by 308
Increasing polypharmacy - an individual-based study of the Swedish population 2005-2008
Hovstadius, B., Hovstadius, K., Åstrand, B., & Petersson, G. (2010) · BMC Clinical Pharmacology · doi:10.1186/1472-6904-10-16 · Cited by 290
Relationship between polypharmacy and underprescribing
Kuijpers, M. A. J., Van Marum, R. J., Egberts, A. C. G., Jansen, P. A. F., & The OLDY (OLd people Drugs & dYsregulations) study group (2008) · British Journal of Clinical Pharmacology · doi:10.1111/j.1365-2125.2007.02961.x · Cited by 253
Inappropriate prescribing: a systematic overview of published assessment tools
Kaufmann, C. P., Tremp, R., Hersberger, K. E., & Lampert, M. L. (2014) · European Journal of Clinical Pharmacology · doi:10.1007/s00228-013-1575-8 · Cited by 246
Conn, V. S., Hafdahl, A. R., Cooper, P. S., Ruppar, T. M., Mehr, D. R., & Russell, C. L. (2009) · The Gerontologist · doi:10.1093/geront/gnp037 · Cited by 227
Payne, R. A., Abel, G. A., Avery, A. J., Mercer, S. W., & Roland, M. O. (2014) · British Journal of Clinical Pharmacology · doi:10.1111/bcp.12292 · Cited by 204
Bradley, M. C., Fahey, T., Cahir, C., Bennett, K., O’Reilly, D., Parsons, C., & Hughes, C. M. (2012) · European Journal of Clinical Pharmacology · doi:10.1007/s00228-012-1249-y · Cited by 177
Self-citationThe benefits and harms of deprescribing
Reeve, E., Shakib, S., Hendrix, I., Roberts, M. S., & Wiese, M. D. (2014) · The Medical Journal of Australia · doi:10.5694/mja13.00200 · Cited by 133
Sumukadas, D., McMurdo, M. E. T., Mangoni, A. A., & Guthrie, B. (2013) · Age and Ageing · doi:10.1093/ageing/aft199 · Cited by 131
Underprescription of Beneficial Medicines in Older People: Causes, Consequences and Prevention
Cherubini, A., Corsonello, A., & Lattanzio, F. (2012) · Drugs & Aging · doi:10.2165/11631750-000000000-00000 · Cited by 129
Looking Beyond Polypharmacy: Quantification of Medication Regimen Complexity in the Elderly
Mansur, N., Weiss, A. T., & Beloosesky, Y. (2012) · The American Journal of Geriatric Pharmacotherapy · doi:10.1016/j.amjopharm.2012.06.002 · Cited by 125
Polypharmacy: a necessary evil
Wise, J. (2013) · BMJ · doi:10.1136/bmj.f7033 · Cited by 123
First do no harm: a real need to deprescribe in older patients
Scott, I. A., Anderson, K., Freeman, C. R., & Stowasser, D. A. (2014) · The Medical Journal of Australia · doi:10.5694/mja14.00146 · Cited by 123
Carey, I. M., Wilde, S. D., Harris, T. J., Victor, C. R., Richards, N., Hilton, S. R., & Cook, D. G. (2008) · Drugs & Aging · doi:10.2165/00002512-200825080-00006 · Cited by 117
Fixed-dose combination therapy for the prevention of cardiovascular disease
de Cates, A. N., Farr, M. R. B., Wright, N., Jarvis, M. C., Rees, K., Ebrahim, S. B. J., & Huffman, M. D. (2014) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd009868.pub2 · Cited by 116
Hancock, H. C., Close, H. J., Fuat, A., Murphy, J. J., Hungin, A. P. S., & Mason, J. M. (2014) · BMJ Open · doi:10.1136/bmjopen-2013-003866 · Cited by 115
Benefits of deprescribing on patients’ adherence to medications
Reeve, E., & Wiese, M. D. (2013) · International Journal of Clinical Pharmacy · doi:10.1007/s11096-013-9871-z · Cited by 112
Galvin, R., Moriarty, F., Cousins, G., Cahir, C., Motterlini, N., Bradley, M. C., Hughes, C. M., Bennett, K., Smith, S. M., Fahey, T. P., et al. (2014) · European Journal of Clinical Pharmacology · doi:10.1007/s00228-014-1651-8 · Cited by 104
Self-citationAronson, J. K. (2004) · British Journal of Clinical Pharmacology · doi:10.1111/j.1365-2125.2004.02067.x · Cited by 89
The development of the PROMPT (PRescribing Optimally in Middle-aged People’s Treatments) criteria
Cooper, J. A., Ryan, C. A., Smith, S. M., Wallace, E., Bennett, K., Cahir, C., Williams, D. J., Teeling, M., Fahey, T. P., Hughes, C. M., et al. (2014) · BMC Health Services Research · doi:10.1186/s12913-014-0484-6 · Cited by 71
Self-citationCharacteristics of Randomized Controlled Trials Designed for Elderly: A Systematic Review
Broekhuizen, K., Pothof, A., de Craen, A. J. M., & Mooijaart, S. P. (2015) · PLoS ONE · doi:10.1371/journal.pone.0126709 · Cited by 68
Cahir, C., Moriarty, F., Teljeur, C., Fahey, T. P., & Bennett, K. (2014) · Annals of Pharmacotherapy · doi:10.1177/1060028014552821 · Cited by 67
Franchi, C., Tettamanti, M., Pasina, L., Djignefa, C. D., Fortino, I., Bortolotti, A., Merlino, L., & Nobili, A. (2014) · European Journal of Clinical Pharmacology · doi:10.1007/s00228-013-1621-6 · Cited by 61
Akbarov, A., Kontopantelis, E., Sperrin, M., Stocks, S. J., Williams, R., Rodgers, S., Avery, A. J., Buchan, I. E., & Ashcroft, D. M. (2015) · Drug Safety · doi:10.1007/s40264-015-0304-x · Cited by 45
Belfrage, B., Koldestam, A., Sjöberg, C., & Wallerstedt, S. M. (2015) · European Journal of Clinical Pharmacology · doi:10.1007/s00228-014-1792-9 · Cited by 33
Cited by
What is polypharmacy? A systematic review of definitions
Masnoon, N., Shakib, S., Kalisch-Ellett, L., & Caughey, G. E. (2017) · BMC Geriatrics · doi:10.1186/s12877-017-0621-2 · Cited by 3,293
Interventions to improve the appropriate use of polypharmacy for older people
Patterson, S. M., Cadogan, C. A., Kerse, N., Cardwell, C. R., Bradley, M. C., Ryan, C., & Hughes, C. (2014) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd008165.pub3 · Cited by 754
Self-citationInterventions to improve the appropriate use of polypharmacy for older people
Rankin, A., Cadogan, C. A., Patterson, S. M., Kerse, N., Cardwell, C. R., Bradley, M. C., Ryan, C., & Hughes, C. (2018) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd008165.pub4 · Cited by 511
Self-citationThe epidemiology of polypharmacy in older adults: register-based prospective cohort study
Morin, L., Johnell, K., Laroche, M.-L., Fastbom, J., & Wastesson, J. W. (2018) · Clinical Epidemiology · doi:10.2147/clep.s153458 · Cited by 376
Green nephrology and eco-dialysis: A position statement by the Italian Society of Nephrology
On the Behalf of Conservative treatment, P. A. A. P. D. P. G. O. T. I. S. O. N., Piccoli, G. B., Cupisti, A., Aucella, F., Regolisti, G., Lomonte, C., Ferraresi, M., Claudia, D., Ferraresi, C., Russo, R., et al. (2020) · Journal of Nephrology · doi:10.1007/s40620-020-00734-z · Cited by 133
Metadata
- Authors
- Cadogan, C. A., Ryan, C., & Hughes, C. M.
- Venue
- Drug Safety
- Published
- 2015-12-21
- Volume
- 39
- Issue
- 2
- Pages
- 109-116
- ISSN
- 0114-5916 (ISSN-L)
- 1179-1942
- OpenAlex
- W2255880215
- Cited by
- 298
- References
- 46
- FWCI
- 5.62
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.